01.02.2013 Views

Insect Control: Biological and Synthetic Agents - Index of

Insect Control: Biological and Synthetic Agents - Index of

Insect Control: Biological and Synthetic Agents - Index of

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

generated in control neonates infected with wildtype<br />

RoMNPV. The ST50s <strong>of</strong> Ro6.9LqhIT2 infected<br />

neonate H. zea <strong>and</strong> H. virescens were also significantly<br />

lower than control neonates infected with a<br />

recombinant RoMNPV expressing AaIT under the<br />

p6.9 promoter.<br />

Chejanovsky et al. (1995) have generated a<br />

recombinant AcMNPV (AcLa22) that expresses the<br />

L. quinquestriatus hebraeus derived alpha toxin,<br />

LqhaIT (Eitan et al., 1990). The LT50 <strong>of</strong> AcLa22<br />

was roughly 35% faster (78 versus 120 h) than that<br />

<strong>of</strong> the wild-type AcMNPV in larvae <strong>of</strong> H. armigera.<br />

Since the LqhaIT toxin binds at a different site on<br />

the insect sodium channel from that <strong>of</strong> the excitatory<br />

toxins (Zlotkin et al., 1978; Cestele <strong>and</strong> Catterall,<br />

2000), Chejanovsky et al. (1995) suggested that a<br />

baculovirus expressing both alpha <strong>and</strong> excitatory<br />

toxins may yield a synergistic interaction between<br />

the toxins. However, they cautioned that LqhaIT<br />

toxin lacks absolute selectivity for insects (Eitan<br />

et al., 1990); thus, a recombinant baculovirus<br />

expressing LqhaIT is not appropriate as a biological<br />

pesticide. The LqhaIT toxin, however, should be an<br />

effective tool to study the targeting <strong>of</strong> different types<br />

<strong>of</strong> toxins on the voltage gated sodium channel. The<br />

effectiveness <strong>of</strong> the use <strong>of</strong> multiple synergistic toxins<br />

is discussed below. Other examples <strong>of</strong> the expression<br />

<strong>of</strong> insect selective toxins from L. quinquestriatus<br />

hebraeus using alternative promoters, signal<br />

sequences for secretion, viral vectors, <strong>and</strong>/or insertion<br />

<strong>of</strong> the toxin gene at the egt gene locus are given<br />

later in this chapter.<br />

10.3.2. Mite Toxins<br />

The insect-predatory straw itch mite Pyemotes tritici<br />

encodes an insect paralytic neurotoxin TxP-I<br />

that induces rapid, muscle contracting paralysis in<br />

larvae <strong>of</strong> the greater wax moth G. mellonella<br />

(Tomalski et al., 1988, 1989). TxP-I is encoded by<br />

the tox34 gene as a precursor protein <strong>of</strong> 291 amino<br />

acid residues. The mature protein is secreted from<br />

the insect cell following cleavage <strong>of</strong> a 39 amino acid<br />

long signal sequence for secretion (Tomalski <strong>and</strong><br />

Miller, 1991). The mode <strong>of</strong> action <strong>of</strong> TxP-I is unknown,<br />

however, it is highly toxic (even at a dose <strong>of</strong><br />

500 mgkg 1 ) to lepidopteran larvae but not toxic<br />

to mice at a dose <strong>of</strong> 50 mg kg 1 . A recombinant,<br />

occlusion-negative AcMNPV (vEV-Tox34) expressing<br />

the tox34 gene under a modified polyhedrin<br />

promoter (PLSXIV; Ooi et al., 1989) was shown<br />

to paralyze or kill fifth instar larvae <strong>of</strong> T. ni by<br />

2 days post injection with 400 000 pfu <strong>of</strong> BV. In<br />

contrast, control larvae injected with BV <strong>of</strong> wildtype<br />

AcMNPV never showed symptoms <strong>of</strong> paralysis<br />

(Tomalski <strong>and</strong> Miller, 1991). Tomalski <strong>and</strong> Miller<br />

10: Genetically Modified Baculoviruses for Pest <strong>Insect</strong> <strong>Control</strong> 345<br />

(1991, 1992) have constructed two other occlusionnegative<br />

AcMNPVs that express the tox34 gene<br />

under early (vETL-Tox34) or hybrid late/very late<br />

(vCappolh-Tox34) gene promoters as well as an<br />

occlusion-positive AcMNPV (vSp-Tox34) expressing<br />

tox34 under a different hybrid late/very late<br />

promoter. The activities <strong>of</strong> these constructs will<br />

be discussed later in this chapter. Lu et al. (1996)<br />

have constructed an occlusion-positive AcMNPV<br />

(vp6.9tox34) that utilizes the late p6.9 promoter<br />

to drive expression <strong>of</strong> tox34. Use <strong>of</strong> this late promoter<br />

resulted in earlier, by at least 24 h, <strong>and</strong> higher<br />

level <strong>of</strong> TxP-I expression in comparison to TxP-I<br />

expression under a very late promoter. As discussed<br />

above, the p6.9 gene promoter is not an<br />

early promoter, but is activated earlier <strong>and</strong> can<br />

drive higher levels <strong>of</strong> expression than very late promoters<br />

in tissue culture (Hill-Perkins <strong>and</strong> Possee,<br />

1990; Bonning et al., 1994). In time-mortality<br />

bioassays (at an LC95 dose), the median time to<br />

effect (ET 50) <strong>of</strong> vp6.9tox34 in neonate larvae <strong>of</strong><br />

S. frugiperda <strong>and</strong> T. ni was reduced by approximately<br />

56% (44.7 versus 101.3 h) <strong>and</strong> 58% (41.7<br />

versus 99.0 h), respectively, in comparison to wildtype<br />

AcMNPV. In neonate S. frugiperda <strong>and</strong> T. ni,<br />

the earlier <strong>and</strong> higher level <strong>of</strong> TxP-I expression<br />

under the late promoter resulted in a 20–30% faster<br />

induction <strong>of</strong> effective paralysis or death in comparison<br />

to TxP-I expression under the very late gene<br />

promoter.<br />

Burden et al. (2000) have constructed a slightly<br />

different TxP-I encoding gene (tox34.4) by RT-PCR<br />

<strong>of</strong> mRNAs purified from total RNA extracted from<br />

P. tritici using primers designed to amplify the tox34<br />

open reading <strong>of</strong> Tomalski <strong>and</strong> Miller (1991). A<br />

recombinant AcMNPV (AcTOX34.4) expressing<br />

TxP-I under the p10 promoter has been generated.<br />

The LD50s <strong>of</strong> AcTOX34.4 were not significantly<br />

different than those <strong>of</strong> the wild-type AcMNPV in<br />

dose-mortality bioassays <strong>of</strong> second (9.3 polyhedra<br />

per larva) <strong>and</strong> fourth (13.1 polyhedra per larva)<br />

instar larvae <strong>of</strong> T. ni. In time-mortality bioassays,<br />

second <strong>and</strong> fourth instar larvae <strong>of</strong> T. ni infected with<br />

AcTOX34.4 showed a 50–60% reduction (depending<br />

on virus dose <strong>and</strong> instar) in the mean time to<br />

death in comparison to control larvae infected with<br />

wild-type AcMNPV. There was also a dramatic<br />

reduction in the yield <strong>of</strong> progeny virus (number <strong>of</strong><br />

polyhedra per mg <strong>of</strong> cadaver) at the time <strong>of</strong> death.<br />

Second <strong>and</strong> fourth instar larvae <strong>of</strong> T. ni that were<br />

infected with AcTOX34.4 produced roughly 85%<br />

<strong>and</strong> 95% lower yields <strong>of</strong> polyhedra per unit<br />

weight, respectively, in comparison to control larvae<br />

infected with AcMNPV. On the basis <strong>of</strong> pathogen–<br />

host model systems that describe how insect viruses

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!